Expression of degradative enzymes and protease inhibitors in corneas with keratoconus

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 7, 1998, Pages 1117-1124

  Zhou, Lili ^a   Sawaguchi, Shoichi ^a,d   Twining, Sally S ^b   Sugar, Joel ^a   Feder, Robert S ^c   Yue, Beatrice Y J T ^a,e  

^a UNIVERSITY OF ILLINOIS   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NIIGATA UNIVERSITY   (Japan)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ASPARTIC PROTEINASE; CATHEPSIN B; CATHEPSIN G; CYSTEINE PROTEINASE; LYSOSOME ENZYME; MATRIX METALLOPROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATOCONUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031806680     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related non-inflammatory corneal disorders. Surv Ophthalmol. 1984;28:293-322.
2. Bron AJ. Keratoconus. Cornea. 1988;7:163-169.
3. Rabinowitz YS, Garbus J, McDonnell PJ. Computer-assisted corneal topography in family members of keratoconus. Arch Ophthalmol. 1990;108:365-371.
4. Jacobs DS, Dohlman CH. Is keratoconus genetic? Int Ophthalmol Clin. 1993;33:249-260.
5. Coyle JT. Keratoconus and eye rubbing. Am J Ophthalmol. 1984; 97:527-528.
6. Yue BYJT, Sugar J, Benveniste K. Heterogeneity in keratoconus: possible biochemical basis. Proc Soc Exp Biol Med. 1985;175:336-341.
7. Critchfield JW, Calandra AJ, Nesburn AB, Kenney MC. Keratoconus. I. Biochemical studies of normal and keratoconus corneas. Exp Eye Res. 1988;46:953-963.
8. Yue BYJT, Sugar J, Benveniste K. RNA metabolism in cultures of corneal stromal cells from patients with keratoconus. Proc Soc Exp Biol Med. 1985;178:126-132.
9. Sawaguchi S, Yue BYJT, Sugar J, Gilboy JE. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol. 1989;107:1507-1510.
10. Sawaguchi S, Twining SS, Yue BYJT, Wilson PM, Sugar J, Chan S-K. α1-Proteinase inhibitor levels in keratoconus. Exp Eye Res. 1990; 50:549-554.
11. Sawaguchi S, Twining SS, Yue BYJT, et al. α2-Macroglobulin levels in normal human and keratoconus corneas. Invest Ophthalmol Vis Sci. 1994;35:4008-4014.
12. Brown D, Chwa MM, Opbroek A, Kenney MC. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res. 1993;12:571-581.
13. Whitelock RB, Fukuchi T, Zhou L, et al. Cathepsin G, acid phosphatase, and α1-proteinase inhibitor messenger RNA levels in keratoconus corneas. Invest Ophthalmol Vis Sci. 1997;38:529-534.
14. Fini ME, Yue BYJT, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal human and keratoconus corneas. Curr Eye Res. 1992;9:849-862.
15. Kao WWY, Vergnes JP, Ebert J, SundarRaj CV, Brown SI. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun. 1982;107:929-936.
16. Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol. 1982;14:751-754.
17. Aronson NN, Barrett AJ. The specificity of cathepsin B. Biochem J. 1978;171:759-765.
18. Barrett AJ. Cathepsin G. Methods Enzymol. 1980;80:561-565.
19. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139-266.
20. Pedcrsen LC, Lund LR, Nielsen LS, Dano K, Skriver L. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem. 1988;263:11189-11195.
21. Woessner JF Jr. The family of matrix metalloproteinases. Ann NY Acad Sci. 1994;732:11-21.
22. Birkedl-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol. 1995;7:728-735.
23. Hekman CM, Loskutoff DJ. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem. 1985;260:11581-11587.
24. Travis J, Guzdek A, Potempa J, Watorek W. Serpins: structure and mechanism of action. Biol Chem Hoppe-Seyler. 1992;371(suppl): 3-11.
25. Holmes WE, Nelles L, Lijnen HR, Collen D. Primary structure of human α2-antiplasmin, a serine protease inhibitor (serpin). J Biol Chem. 1987;262:1659-1664.
26. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 1995;9:974-980.
27. Zhou L, Yue BYJT, Twining SS, Sugar J, Feder RS. Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res. 1996;15:1124-1131.
28. LaBarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980;102:344-352.
29. Sawaguchi S, Yue BYJT, Kawa JE, Chang IL, Twining SS, Meberg B. Lysosomal enzyme and inhibitor levels in the human trabecular meshwork. Invest Ophthalmol Vis Sci. 1994;35:251-261.
30. Smith RE, Bissell ER, Mitchell AR, Pearson KW. Direct photometric or fluorometric assay of proteinases using substrates containing 7-amino-4-trifluoromethyl coumarin. Thromb Res. 1980;17:393-402.
31. Castillo MJ, Nakajima K, Zimmerman M, Powers JC. Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases. Anal Biochem. 1979; 99:53-64.
32. Ando H, Twining SS, Yue BYJT, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci. 1993;34:3541-3548.
33. Tripathi BJ, Geanon JD, Tripathi RC. Distribution of tissue plasminogen activator in human and monkey eyes: an immunohistochemical study. Ophthalmology. 1987;94:1434-1438.
34. Twining SS, Fukuchi T, Yue BYJT, Wilson PM, Zhou X. α1-Antichymotrypsin is present and synthesized by the cornea. Curr Eye Res. 1994;13:433-439.
35. Tripathi R, Tripathi BJ, Park JK. Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study. Exp Eye Res. 1990;51:545-552.
36. Wang PH, Do YS, Macaulay L, et al. Identification of renal cathepsin B as a human prerenin-processing enzyme. J Biol Chem. 1991; 266:12633-12638.
37. Neurath H, Walsh KA. Role of proteolytic enzymes in biological regulation. Proc Natl Acad Sci USA. 1976;73:3825-3832.
38. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol. 1989;1:974-982.
39. Jessup JM. Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol. 1994;145:1-11.
40. Bechet DM, Ferrar MJ, Mordier SB, Roux MP, Deval CD, Obled A. Expression of lysosomal cathepsin B during calf myoblast-myotube differentiation. J Biol Chem. 1991;266:14104-14112.
41. Whitelock RB, Li Y, Zhou L, Sugar J, Yue BYJT. Expression of transcription factors in keratoconus, a cornea-thinning disease. Biochem Biophys Res Commun. 1997;235:253-258.
42. Berquin IM, Sloane BF. Cathepsin B expression in human tumors. In: Suzuki K, Bond J, eds. Intracellular Protein Catabolism. New York: Plenum Press; 1996:281-294.
43. Heusel JW, Hanson RD, Silverman GA, Ley TJ. Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. J Biol Chem. 1991;266: 6152-6158.
44. Ihlainen A, Salo T, Forsius H, Peltonen L. Increase in type I and type IV collagenolytic activity in primary cultures of keratoconus cornea. Eur J Clin Invest. 1986;16:78-84.
45. Kenney MC, Chwa M, Escobar M, Brown D. Altered gelatinolytic activity by keratoconus corneal cells. Biochem Biophys Res Commun. 1989;161:353-357.
46. Trapani JA, Smyth MJ, Apostolidis VA, Dawson M, Browne KA. Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem. 1994;269:18359-18365.
47. Dubrez L, Savoy I, Hamman A, Solary E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 1996;15:5504-5512.